Literature DB >> 12435596

Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf.

Florence Nadal-Wollbold1, Marc Pawlowski, Sylviane Lévy-Toledano, Eliane Berrou, Jean Philippe Rosa, Marijke Bryckaert.   

Abstract

Extracellular signal-regulated kinase (ERK) activation pathways have been well characterized in a number of cell types but very few data are available for platelets. The thrombin-induced signaling pathway leading to ERK2 activation in platelets is largely uncharacterized. In this study, we investigated the kinases involved in thrombin-induced ERK2 activation in conditions of maximal ERK2 activation. We found that thrombin-induced mitogen-activated protein kinase/ERK kinase (MEK)1/2 activation was necessary for ERK2 phosphorylation. We obtained strong evidence that conventional protein kinase Cs (PKCs) and calcium are involved in thrombin-induced ERK2 activation. First, ERK2 and MEK1/2 phosphorylation was totally inhibited by low concentrations (1 microM) of RO318425, a specific inhibitor of conventional PKCs. Second, Ca(2+), from either intracellular pools or the extracellular medium, was necessary for ERK2 activation and conventional PKC activation, excluding the involvement of a new class of calcium-insensitive PKCs. Third, LY294002 and wortmannin had no significant effect on ERK2 activation, even at concentrations that inhibit phosphatidylinositol (PI)3-kinase (5 microM to 25 microM and 50 nM, respectively). This suggests that PI3-kinase was not necessary for ERK2 activation and therefore, that PI3-kinase-dependent atypical PKCs were not involved. Surprisingly, in contrast to proliferative cells, we found that the serine/threonine kinases Raf-1 and B-Raf were not an intermediate kinase between conventional PKCs and MEK1/2. After immunoprecipitation of Raf-1 and B-Raf, the basal glutathione S-transferase-MEK1 phosphorylation observed in resting platelets was not upregulated by thrombin and was still observed in the absence of anti-Raf-1 or anti-B-Raf antibodies. In these conditions, the in vitro cascade kinase assay did not detect any MEK activity. Thus in platelets, thrombin-induced ERK2 activation is activated by conventional PKCs independently of Raf-1 and B-Raf activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435596     DOI: 10.1016/s0014-5793(02)03587-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Platelet MEKK3 regulates arterial thrombosis and myocardial infarct expansion in mice.

Authors:  Xuemei Fan; Conghui Wang; Panlai Shi; Wen Gao; Jianmin Gu; Yan Geng; Wenlong Yang; Ningbo Wu; Yang Wang; Yanyan Xu; Xue Chen; Lin Zhang; Kemin Wang; Bing Su; Junling Liu
Journal:  Blood Adv       Date:  2018-06-26

2.  C3G contributes to platelet activation and aggregation by regulating major signaling pathways.

Authors:  Cristina Fernández-Infante; Luis Hernández-Cano; Sara Gutiérrez-Herrero; Sara Ortiz-Rivero; Carlos Guijas; Víctor Martín-Granado; José Ramón González-Porras; Jesús Balsinde; Almudena Porras; Carmen Guerrero
Journal:  Signal Transduct Target Ther       Date:  2020-04-01

3.  Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.

Authors:  Jennifer Yeung; Patrick L Apopa; Joanne Vesci; Victor Kenyon; Ganesha Rai; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney; Olivier Boutaud; Michael Holinstat
Journal:  Mol Pharmacol       Date:  2011-12-09       Impact factor: 4.436

4.  Ask1 regulates murine platelet granule secretion, thromboxane A2 generation, and thrombus formation.

Authors:  Meghna U Naik; Pravin Patel; Randall Derstine; Ramya Turaga; Xi Chen; Kalyan Golla; Keith B Neeves; Hidenori Ichijo; Ulhas P Naik
Journal:  Blood       Date:  2016-12-27       Impact factor: 22.113

5.  Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.

Authors:  Karen Cichowski; Sabrina Santiago; Melanie Jardim; Bryan W Johnson; Tyler Jacks
Journal:  Genes Dev       Date:  2003-02-15       Impact factor: 11.361

6.  The protein tyrosine phosphatase PTPN7 is a negative regulator of ERK activation and thromboxane generation in platelets.

Authors:  Vaishali V Inamdar; Haritha Reddy; Carol Dangelmaier; John C Kostyak; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2019-07-02       Impact factor: 5.157

7.  Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and alpha-granule release.

Authors:  Sybille Rex; Lea M Beaulieu; David H Perlman; Olga Vitseva; Price S Blair; Mark E McComb; Catherine E Costello; Jane E Freedman
Journal:  Thromb Haemost       Date:  2009-07       Impact factor: 5.249

8.  Impaired activation of platelets lacking protein kinase C-theta isoform.

Authors:  Bela Nagy; Kamala Bhavaraju; Todd Getz; Yamini S Bynagari; Soochong Kim; Satya P Kunapuli
Journal:  Blood       Date:  2009-01-22       Impact factor: 22.113

Review 9.  Platelets and tumor-associated RNA transfer.

Authors:  Silvia D'Ambrosi; R Jonas Nilsson; Thomas Wurdinger
Journal:  Blood       Date:  2021-06-10       Impact factor: 22.113

10.  Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.

Authors:  Kristof Van Kolen; Herman Slegers
Journal:  Purinergic Signal       Date:  2006-06-07       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.